222 related articles for article (PubMed ID: 29573228)
1. A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women.
White DL; Hoogeveen RC; Chen L; Richardson P; Ravishankar M; Shah P; Tinker L; Rohan T; Whitsel EA; El-Serag HB; Jiao L
Cancer Med; 2018 May; 7(5):2180-2191. PubMed ID: 29573228
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women.
Chen L; Duan Z; Tinker L; Sangi-Haghpeykar H; Strickler H; Ho GY; Gunter MJ; Rohan T; Logsdon C; White DL; Royse K; El-Serag HB; Jiao L
Cancer Epidemiol; 2016 Jun; 42():115-23. PubMed ID: 27100837
[TBL] [Abstract][Full Text] [Related]
3. Soluble Receptor for Advanced Glycation End-products (sRAGE) and Colorectal Cancer Risk: A Case-Control Study Nested within a European Prospective Cohort.
Aglago EK; Rinaldi S; Freisling H; Jiao L; Hughes DJ; Fedirko V; Schalkwijk CG; Weiderpass E; Dahm CC; Overvad K; Eriksen AK; Kyrø C; Boutron-Ruault MC; Rothwell JA; Severi G; Katzke V; Kühn T; Schulze MB; Aleksandrova K; Masala G; Krogh V; Panico S; Tumino R; Naccarati A; Bueno-de-Mesquita B; van Gils CH; Sandanger TM; Gram IT; Skeie G; Quirós JR; Jakszyn P; Sánchez MJ; Amiano P; Huerta JM; Ardanaz E; Johansson I; Harlid S; Perez-Cornago A; Mayén AL; Cordova R; Gunter MJ; Vineis P; Cross AJ; Riboli E; Jenab M
Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):182-192. PubMed ID: 33082206
[TBL] [Abstract][Full Text] [Related]
4. Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study.
Jiao L; Weinstein SJ; Albanes D; Taylor PR; Graubard BI; Virtamo J; Stolzenberg-Solomon RZ
Cancer Res; 2011 May; 71(10):3582-9. PubMed ID: 21540233
[TBL] [Abstract][Full Text] [Related]
5. Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.
Gunter MJ; Wang T; Cushman M; Xue X; Wassertheil-Smoller S; Strickler HD; Rohan TE; Manson JE; McTiernan A; Kaplan RC; Scherer PE; Chlebowski RT; Snetselaar L; Wang D; Ho GY
J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26185195
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
[TBL] [Abstract][Full Text] [Related]
7. Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer.
Ollberding NJ; Kim Y; Shvetsov YB; Wilkens LR; Franke AA; Cooney RV; Maskarinec G; Hernandez BY; Henderson BE; Le Marchand L; Kolonel LN; Goodman MT
Cancer Prev Res (Phila); 2013 Mar; 6(3):188-95. PubMed ID: 23466816
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer.
Jiao L; Taylor PR; Weinstein SJ; Graubard BI; Virtamo J; Albanes D; Stolzenberg-Solomon RZ
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1430-8. PubMed ID: 21527578
[TBL] [Abstract][Full Text] [Related]
9. Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort.
Dallal CM; Brinton LA; Bauer DC; Buist DS; Cauley JA; Hue TF; Lacroix A; Tice JA; Chia VM; Falk R; Pfeiffer R; Pollak M; Veenstra TD; Xu X; Lacey JV;
Endocr Relat Cancer; 2013 Feb; 20(1):151-60. PubMed ID: 23222000
[TBL] [Abstract][Full Text] [Related]
10. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
Melin EO; Dereke J; Hillman M
Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
[TBL] [Abstract][Full Text] [Related]
11. Association between pre-diagnostic circulating adipokines and colorectal cancer and adenoma in the CLUE II cohort.
Marrone MT; Lu J; Visvanathan K; Joshu CE; Platz EA
Cancer Causes Control; 2021 Aug; 32(8):871-881. PubMed ID: 33999316
[TBL] [Abstract][Full Text] [Related]
12. Relationship between soluble receptor for advanced glycation end products (sRAGE), body composition and fat distribution in healthy women.
Dozio E; Briganti S; Delnevo A; Vianello E; Ermetici F; Secchi F; Sardanelli F; Morricone L; Malavazos AE; Corsi Romanelli MM
Eur J Nutr; 2017 Dec; 56(8):2557-2564. PubMed ID: 27522371
[TBL] [Abstract][Full Text] [Related]
13. Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: a prospective study.
Gross AL; Newschaffer CJ; Hoffman-Bolton J; Rifai N; Visvanathan K
Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1319-24. PubMed ID: 23651666
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Kurita-Nakamura Y; Matsui T; Yoshida T; Imaizumi T
Mol Med; 2007; 13(3-4):185-9. PubMed ID: 17592553
[TBL] [Abstract][Full Text] [Related]
15. Association of plasma advanced glycation end-products and their soluble receptor with type 2 diabetes among Chinese adults.
Chen L; Wang Q; Lv Y; Xu W; Jiang G; Li Y; Luo P; He R; Liu L
Diabetes Metab Res Rev; 2024 Feb; 40(2):e3735. PubMed ID: 37817474
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of advanced glycation end products (AGEs) are increased and their soluble receptor (sRAGE) reduced in Hashimoto's thyroiditis.
Ruggeri RM; Barbalace MC; Cristani MT; Alibrandi A; Giovinazzo S; Giuffrida G; Trimarchi F; Cannavò S; Campennì A
J Endocrinol Invest; 2020 Sep; 43(9):1337-1342. PubMed ID: 32232775
[TBL] [Abstract][Full Text] [Related]
17. Receptor for advanced glycation end products (RAGE) soluble form (sRAGE): a new biomarker for lung cancer.
Jing R; Cui M; Wang J; Wang H
Neoplasma; 2010; 57(1):55-61. PubMed ID: 19895173
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts.
Bao Y; Giovannucci EL; Kraft P; Stampfer MJ; Ogino S; Ma J; Buring JE; Sesso HD; Lee IM; Gaziano JM; Rifai N; Pollak MN; Cochrane BB; Kaklamani V; Lin JH; Manson JE; Fuchs CS; Wolpin BM
J Natl Cancer Inst; 2013 Jan; 105(2):95-103. PubMed ID: 23243202
[TBL] [Abstract][Full Text] [Related]
19. Adipokines linking obesity with colorectal cancer risk in postmenopausal women.
Ho GY; Wang T; Gunter MJ; Strickler HD; Cushman M; Kaplan RC; Wassertheil-Smoller S; Xue X; Rajpathak SN; Chlebowski RT; Vitolins MZ; Scherer PE; Rohan TE
Cancer Res; 2012 Jun; 72(12):3029-37. PubMed ID: 22511581
[TBL] [Abstract][Full Text] [Related]
20. Is there any evidence that AGE/sRAGE is a universal biomarker/risk marker for diseases?
Prasad K
Mol Cell Biochem; 2019 Jan; 451(1-2):139-144. PubMed ID: 29961210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
